Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2658682 | 0.80 | PTP4A3 (0.46) | ALDH1A1PTP4A3TP53TDP1TRPA1 | |
| SCHEMBL28734149 | 0.76 | NFE2L2 (0.41) | ALDH1A1TP53LMNAMAPTTDP1 | |
| SCHEMBL29603833 | 0.76 | NFE2L2 (0.41) | ALDH1A1TP53LMNAMAPTTDP1 | |
| SCHEMBL29662132 | 0.73 | NFE2L2 (0.50) | ALDH1A1TP53LMNAMAPTTDP1 | |
| SCHEMBL248639 | 0.73 | NFE2L2 (0.50) | ALDH1A1TP53LMNAMAPTTDP1 | |
| SCHEMBL4758378 | 0.72 | ALDH1A1 (0.34) | ALDH1A1TP53TDP1TRPA1 | |
| SCHEMBL95486 | 0.72 | CES2 (0.43) | ALDH1A1TDP1 | |
| SCHEMBL11427991 | 0.71 | MCL1 (0.35) | ALDH1A1TDP1TRPA1 | |
| SCHEMBL22869168 | 0.70 | ALDH1A1 (0.46) | ALDH1A1TP53LMNAMAPTTDP1 | |
| SCHEMBL27613550 | 0.70 | PTGDR2 (0.40) | ALDH1A1TP53TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009003009-A1 | SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |